Are you navigating the strict cross-border transfer rules under the DPDP Act? Discover how US health-tech entities can achieve compliance as a massive competitive B2B sales advantage in India. The Indian digital health ecosystem is expanding at an unprecedented rate, offering a highly lucrative market for US-based health-tech firms. From AI-driven diagnostics to telemedicine infrastructure,...

For US-based Software-as-a-Service (SaaS) companies looking to establish Global Capability Centers (GCCs) or offshore engineering hubs, the default strategy has historically pointed to one city: Bangalore. However, as we navigate 2026, the financial and operational realities of India’s Tier-1 tech capitals are shifting drastically. Saturated infrastructure, hyper-competitive talent wars, and skyrocketing real estate costs are...

Details the RBI’s new IRACP Amendment directions forcing NBFCs to recompute ECL provisions under Ind AS 1 for DLG portfolios. The regulatory environment for Non-Banking Financial Companies (NBFCs) and digital lending platforms in India has reached a critical inflection point. In an aggressive move to tighten systemic risk and enhance balance sheet transparency, the Reserve...

The final weeks of the financial year represent a period of intense operational pressure for corporate finance departments. Between closing the books and reconciling supplier invoices, Chief Financial Officers (CFOs) must also navigate the rigid statutory mandates of the Companies Act, 2013. A major pain point has been the Corporate Social Responsibility (CSR) expenditure requirement,...

Global Capability Centers in 2026: Dealing with the 15.5% IT Safe Harbor The situation with Global Capability Centers in India has changed a lot in 2026. For people in charge of money and taxes at US companies, the big problem has always been “transfer pricing issues”. The risk that Indian tax authorities will question the...

100 percent FDI Insurance Opportunity: Cross-border Acquisitions Structuring With the enactment of the Sabka Bima Act, 2026, the Indian insurance industry has embarked on a transformative period, given the introduction of the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2026, widely known as the Sabka Bima Act. To the US conglomerates and international...

The Role of TReDS Integration and Zero-Day Working Capital in Indian Corporate Finance   In the corporate finance world, having enough money to meet daily needs is very important. For the people in charge of companies, like CEOs and CFOs, managing the time it takes to get money from customers is a challenge. They have...

The 2026 Pivot: Why US Venture Capital Must Rethink Indian Exits For PE/VC firms based in the US, India has always presented itself as a high-growth market opportunity. Nonetheless, there is a major shake-up coming in terms of capital repatriation regulations in the jurisdiction. By the year 2026, the change from capital gain treatment of...

Introduction: The Liquidity Challenge in Global Supply Chains For United States-based electronics manufacturers and high-tech capital equipment providers, the Indian market represents massive growth potential. However, establishing a localized supply chain has historically presented a severe liquidity challenge. Importing critical components meant paying steep upfront customs duties long before the final product was sold, trapping...

Introduction: The Shifting Center of Global Manufacturing For United States electronics manufacturers, the search for a resilient, cost-effective alternative to traditional East Asian manufacturing hubs has been a decade-long boardroom priority. The “China Plus One” strategy was often hindered by complex export duties and unpredictable tariff structures. The ratification of the US-India Trade Deal in...

Introduction: The Pillar Two Reality for US Multinationals For Chief Financial Officers (CFOs) of United States-parented multinational enterprises (MNEs), global tax planning has entered its most complex era. The OECD’s Pillar Two framework is no longer a theoretical policy; it is an operational reality. As we approach the sunset of the transitional safe harbors, the...

Introduction: Accelerating the Speed of Science For global Contract Research Organizations (CROs) and pharmaceutical manufacturers, time-to-market is the ultimate competitive advantage. The duration of Research and Development (R&D) phases directly impacts patent exclusivity windows and overall profitability. Historically, India offered unparalleled advantages in clinical diversity and cost arbitrage, but bureaucratic bottlenecks often stalled the initiation...